Fairvalue-Calculator Fairvalue-Calculator
EN DE

Shanghai Haixin Group (900917) Fair Value & Analysis

Industrials · CN · Market cap $299M

Price$0.2630
Fair Value$0.8138
Upside+209.4%
Quality90/100
Evidence: High Range $0.5988 – $1.01

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Shanghai Haixin Group (900917) currently trades at $0.2630, while our model-based Fair Value estimate is $0.8138 — implying the stock looks roughly 209.4% undervalued today. We read business quality at 90/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company was founded in 1986 and is headquartered in Shanghai, China.

Open the full interactive analysis →

Similar stocks

Honeywell International Inc (HON) -38% Hitachi, Ltd (HTHIY) +4% CITIC Limited (0267) +63% CK Hutchison Holdings (0001) +114% Itaúsa S.A (ITSA3) -0% SK Inc (034730) -16%

Frequently asked questions

Is Shanghai Haixin Group (900917) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.8138 versus a price of $0.2630 — about +209% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 900917?
Our 21-model fair value for Shanghai Haixin Group is $0.8138 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.2630.
What is the quality score of 900917?
Shanghai Haixin Group has a Quality Score of 90/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.